Clinical Trial: Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis

U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07076108) titled 'Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis' on July 13.

Brief Summary: The study aimed to evaluate the safety and efficacy of oral vitamin C administration on erythropoietin dosing requirement in end-stage renal disease patients on regular hemodialysis.

Study Start Date: Aug. 01, 2019

Study Type: INTERVENTIONAL

Condition: Vitamin C Oral Administration Erythropoietin End-Stage Renal Disease Regular Hemodialysis

Intervention: DRUG: Normal regimen of treatment of anemia

Patients were on normal regimen of treatment of anemia.

DRUG: Vitamin C

Pat...